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Abstract
Simian immunodeficiency virus (SIV) and human immunodeficiency virus (HIV-1) preferentially select and use tRNALys,3 as the primer for
initiation of reverse transcription. Previous studies have shown that HIV-1 can be forced to use tRNAGlu if mutations are made within the primer-
binding site (PBS) and a region upstream, A-loop, to be complementary to the 3′-terminal 18 nucleotides and anticodon loop of tRNAGlu. To
examine the primer preference of SIV, mutations were made within the PBS of SIVsmmPBj to be complementary to tRNA
Glu. Analysis of the
production of infectious virus revealed that SIVsmmPBj with the PBS complementary to tRNA
Glu retained approximately 80% infectivity of the
wild type. However, modification of the U5 of SIVsmmPBj to alter nucleotides to be complementary to the anticodon of tRNA
Glu, in combination
with the PBS complementary to tRNAGlu, drastically reduced the production of infectious SIVsmmPBj to less than 1% that of wild type. The
replication of SIVsmmPBj with the PBS complementary to tRNA
Glu was similar to that of the wild type virus, while the replication of SIVsmmPBj
with PBS and A-loop complementary to tRNAGlu was delayed compared to that of wild type virus. Analysis of the PBS regions revealed that the
virus with the PBS complementary to tRNAGlu reverted quickly, within 4 days, to be complementary to tRNALys,3, while the virus with PBS and
A-loop complementary to tRNAGlu retained the PBS for a longer time during in vitro culture although following extended replication both the
A-loop and PBS of SIVsmmPBj reverted to be complementary to tRNA
Lys,3. RNA modeling of SIVsmmPBj U5-PBS by m-fold revealed two
potential A-loop regions. Mutations in either A-loop drastically effected replication in human PBMC. Analysis of the A-loops following in vitro
replication revealed that both reverted to the wild type sequence. The results of these studies demonstrate that SIVsmmPBj, like HIV-1,
preferentially utilizes tRNALys,3 as a primer for reverse transcription for high level replication, but unlike HIV-1 selection may involve the use of
two adenosine-rich loops.
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A hallmark in the lifecycle of retroviruses is the process by
which the viral RNA is converted to a DNA intermediate prior
to integration. This process, termed reverse transcription is
catalyzed by a virally encoded enzyme reverse transcriptase. In
order for the reverse transcriptase to copy the viral RNA, a
cellular tRNA is captured and used as the primer for the
initiation of reverse transcription (Baltimore, 1970; Temin and
Mizutani, 1970). The 3′-terminal nucleotides of the tRNA
primer are complementary to a region on the viral genome⁎ Corresponding author. Fax: +1 205 934 1580.
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doi:10.1016/j.virol.2007.04.025designated as the primer-binding site (PBS) (Panet and Berliner,
1978; Peters and Dahlberg, 1979; Temin, 1981).
The tRNA selected by different retroviruses for use as a
primer for reverse transcription can vary between viral species
(Mak and Kleiman, 1997; Marquet et al., 1995). Lentiviruses,
such as HIV and SIV, preferentially select tRNALys,3 as the
primer for initiation of reverse transcription (Mak and Kleiman,
1997; Marquet et al., 1995; Muesing et al., 1985; Ratner et al.,
1985). HIV-1 can be forced to use many different tRNAs as
primers for initiation of reverse transcription by alteration of the
PBS to be complementary to the 3′-terminal 18 nucleotides of
different tRNAs (Das et al., 1995; Li et al., 1994;Wakefield et al.,
1995). However, the preference for the selection and use of
tRNALys,3 as a primer for reverse transcription is manifested by
the fact that all of the viruses revert to utilize tRNALys,3
Fig. 1. HIV-1 and SIVsmmPBj U5 and PBS. (A) Nucleotide sequence of HIV-1
and SIVsmmPBj A-loop and PBS. The nucleotides sequence of the wild type SIV
(SIV-WT) and HIV-1 (NL4-WT) A-loop and PBS regions are depicted. The PBS
for both is complementary to the 3′-terminal 18 nucleotides of tRNALys,3. A
second region consisting of GAAAAT is found in both SIV-WT and NL4-WT.
Proviral genomes were generated in which the PBS was made complementary to
the 3′-terminal nucleotides of tRNAGlu (SIV-Glu or NL4-Glu). Proviral
genomes were constructed in which the A-loop region of SIV-Glu and NL4-
Glu was mutated to be complementary to the anticodon region of tRNAGlu. This
resulted in the alteration of the GAAAAT to TAGAGTTGAGT; proviral clones
were named SIV-GluAC and NL4-GluAC. (B) Infectivity of viruses obtained
following transfection into 293T cells. The proviral genomes were transfected
into 293T cells and activity of the viruses were determined. Analysis of the p27
(SIV) or p24 (HIV-1) produced from the transfected cultures revealed no
differences between the wild type and proviral genomes containing the A-loop
or PBS mutations (data not shown). The amount of infectious virus was
determined using the JC53-BL assay. The infectivity produced from transfection
of wild type (SIV-WT or NL4-WT) was determined and the amounts produced
by the PBS and A-loop mutant proviral genomes were compared to this value.
The data presented represent infectivity compared to the wild type (SIV-WT or
NL4-WT). The data presented are representative of three independent
transfections.
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region in U5 upstream of the PBS, designated as the A-loop,
contained adenosines displayed on a loop structure of a RNA
stem–loop that is postulated to interact with the anticodon region
of tRNALys,3 (Goldschmidt et al., 2002; Isel et al., 1995).
Previous studies from our laboratory have found that viruses
with the A-loop and PBS complementary to the anticodon and 3′
nucleotides of tRNAHis, tRNAMet, tRNALys1,2 and tRNAThr
could stably utilize these tRNAs as primers for initiation of
reverse transcription (Ni and Morrow, 2007; Wakefield et al.,
1996; Zhang et al., 1998). We have also found that viruses with
the A-loop and PBS complementary to tRNAGlu could stably
utilize tRNAGlu as a primer for reverse transcription (Dupuy et
al., 2003). The integrity of the RNA stem–loop encompassing
the nucleotides complementary to the anticodon of tRNAGlu
were demonstrated to be important for the virus to maintain the
PBS complementary to tRNAGlu following in vitro replication.
SIVsmmPBj also contains a PBS that is complementary to
tRNALys,3 (Dewhurst et al., 1990). Presumably, SIVsmmPBj also
preferentially selects tRNALys,3 similar to what has been seen
for HIV-1, although this has not been formally tested. To further
explore the mechanism of lentivirus primer selection, we have
compared the stability of HIV-1 and SIVsmmPBj genomes in
which the PBS has been altered to be complementary to
tRNAGlu following growth in human peripheral blood mono-
nuclear cells (PBMC). SIVsmmPBj has been shown to infect both
macaque or human PBMC (Fultz et al., 1989). The results of
our studies demonstrate that the PBS of SIVsmmPBj and HIV-1
that were altered to be complementary to tRNAGlu differs with
respect to stability of the PBS and virus growth in PBMC.
Analysis of the PBS and A-loop regions from SIVsmmPBj
following replication revealed the presence of at least two
adenosine-rich loops that could possibly influence primer
selection by SIVsmmPBj.
Results
Construction and characterization of SIVsmmPBj viral genomes
with mutated PBS
In a previous study, we described the construction and
characterization of HIV-1 in which the A-loop and PBS have
been mutated to be complementary to the anticodon and 3′-
terminal nucleotides of tRNAGlu (Dupuy et al., 2003). The A-
loop region of HIV-1 consists of four adenosine residues that
previous studies have modeled to be on the crown of an RNA
stem–loop structure. In this study, we found that mutation of
these adenosines to nucleotides that are complementary to the
anticodon of tRNAGlu, along with mutations in the PBS
complementary to tRNAGlu, resulted in a virus that stably
utilized this tRNA for in vitro replication. SIVsmmPBj contains a
PBS that is complementary to tRNALys,3 (Dewhurst et al.,
1990). Upstream of this PBS there are nucleotides identical to
the A-loop region of HIV-1 (a sequence GAAAAT) (Fig. 1A).
For the initial set of experiments, we generated SIV-Glu in
which the PBS alone has been altered to the 3′-terminal 18
nucleotides of tRNAGlu, and a second mutant, SIV-GluAC inwhich the putative A-loop region was also modified to be
complementary to the anticodon of tRNAGlu.
Our first set of experiments characterized the infectivity of
viruses obtained following transfection of the wild type or
mutated proviral genomes into 293T cells. The modification of
the PBS and A-loop did not effect the production of total virus
as measured by p24 antigen (HIV-1) or p27 (SIVsmmPBj) of the
transfection supernatant (data not shown). Previous studies
from our laboratory have shown that HIV-1 genomes in which
the PBS has been altered to be complementary to alternative
Fig. 2. Replication of HIV-1 and SIVsmmPBj with U5-PBS complementary to
tRNAGlu. (A) Replication of wild type HIV-1 and A-loop-PBS mutants.
Infections were initiated in human PBMC using equal amounts of infectious
virus. Supernatants were assayed at the designated intervals for infectious virus
using the JC53-BL assay. The identity of the samples are as indicated. Note that
for NL4-WTand NL4-Glu a break occurred in the production of infectious virus
such that the wild type by Day 14 had peaked at 25,000 rLu/μL whereas NL4-
Glu peaked at Day 31 at 9000 rLu/μL. The amount of infectious virus produced
from NL4-GluAC increased throughout the culture, but peaked at approximately
100 rLu/μL. The data presented are representative of three independent
experiments. (B) Replication of SIV-WT and A-loop-PBS mutants. Infections
were initiated in human PBMC using equal amounts of infectious virus. At 3 to 4
day intervals, supernatants were collected from the infected cultures and
analyzed for production of infectious virus using the JC53-BL assay. The
identity of the samples are as indicated. The data presented is representative of
three independent experiments.
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ity of that of the wild type virus. Consistent with those previous
studies, we found that NL4-Glu or NL4-GluAC had infectivities
approximately 10% that of the wild type virus as determined in
JC53-BL cells. Analysis of the infectivity of SIVsmmPBj with the
PBS complementary to tRNAGlu (SIV-Glu) though gave a
completely different result. In this case, the infectivity obtained
for this virus following transfection was approximately 80%
that of the wild type virus (Fig. 1B). However, inclusion of both
A-loop and PBS complementary to tRNAGlu (SIV-GluAC)
resulted in a virus that had considerably reduced infectivity
approximately 1% of that of the wild type virus.
We next analyzed the replication of these viruses in which
the PBS alone or U5 and PBS were altered to be complementary
to tRNAGlu. Viral replication was determined by measuring the
luciferase activity produced from JC53-BL cells infected with
supernatants from human PBMC at different times of infection.
As expected, wild type HIV-NL4 replicated efficiently in
human PBMC demonstrating a rapid rise in the production of
infectious virus that peaked by 14 days (Fig. 2A). The alteration
of the PBS to be complementary to tRNAGlu (NL4-Glu) had a
drastic effect on the replication of HIV-1. Consistent with the
previous study, we found that the virus with the PBS
complementary to tRNAGlu grew slowly early in culture but
at later times demonstrated a rapid increase in production of
infectious virus that coincided with the reversion of the PBS to
be complementary to tRNALys,3. The virus with the U5 and PBS
complementary to tRNAGlu NL4-GluAC also grew slowly
during the culture period, peaking at approximately 18 days.
Analysis of the PBS of this virus revealed that it maintained
complementarity to tRNAGlu (data not shown).
The replication of SIVsmmPBj in PBMC was considerably
different than HIV-1. First, the wild type virus, as expected,
grew in PBMC reaching a peak at approximately 14 days post
initiation of culture (Fig. 2B). However, the production of
infectious virus by SIVsmmPBj was approximately 20-fold less
than that for HIV-1 grown in human PBMC. SIV-Glu also grew
well in human PBMC reaching a peak at approximately the
same time as the wild type virus. The rapid growth of this virus
in human PBMC is consistent with the infectivity, which
demonstrated that this virus retained approximately 80% of the
infectivity of the wild type virus. In contrast, SIV-GluAC
demonstrated a delay in replication, reaching a peak level
similar to that for the wild type virus after 21 days of the
infection. Thus, in contrast to HIV-1, SIVsmmPBj does not grow
as robustly in human cells and mutations within the PBS and U5
do not seem to effect virus replication as significantly as that for
HIV-1.
We next analyzed the sequence of the U5-PBS region of the
SIVsmmPBj following growth in human PBMC. For these
studies, we utilized PCR to amplify the region containing the
U5-PBS from integrated provirus. In most cases, the PCR
product was TA cloned and individual clones were sequenced to
determine the identity of the PBS. Analysis of SIV-Glu revealed
that by Day 4 post-infection, all of the PBS sequences recovered
were complementary to tRNALys,3, indicating that a reversion to
the wild type PBS had occurred (Table 1). A few additionalnucleotide changes were also noted upstream of the PBS. Thus,
the rapid rise of virus similar to the wild type virus at Day 11
was probably due to the fact that SIV-Glu had already reverted
to utilize tRNALys,3. We next analyzed the U5-PBS sequence of
SIV-GluAC following in vitro replication. At early time points,
Days 4 and 7 the virus maintained a PBS complementary to
tRNAGlu indicating that the alteration in the A-loop sequence of
SIVsmmPBj had stabilized the use of tRNA
Glu as the primer for
replication. However, by Day 14 and Day 21, PBS sequences
complementary to tRNALys,3 were observed. Strikingly though,
we noted the emergence of additional mutations in the mutated
A-loop sequence which had inserted adenosine residues for the
majority of the mutated nucleotides. This would have the
Fig. 3. Potential A-loop regions of SIVsmmPBj. A m-fold of the potential A-loop
regions of SIVsmmPBj is presented. Depicted are two potential A-loop regions
designated as A-loop 1 and A-loop 2. Note that A-loop 2 was altered in the
construction of SIV-GluAC. The first four nucleotides of the PBS complemen-
tary to tRNALys,3 are also depicted.
Table 1
DNA sequences of U5-PBS region of proviruses derived from SIV-Glu and SIV-GluAC grown in human PBMC
a Spaces separate the PBS from flanking sequences. Boldface characters indicate nucleotide changes made from the wild type sequence. Asterisks represent
conserved nucleotides with the input sequence.
b Glu and GluAC input refers to either SIV-Glu or GluAC viruses used to initiate culture. PCR products were sequenced directly when indicated. Sequences of
cloned PCR products are shown as frequencies of TA clones analyzed (i.e. number observed over total number analyzed).
c Number of days post inoculation of culture.
d PBS complementary to the 3′-terminal 18 nucleotides of tRNALys,3.
e PBS complementary to the 3′-terminal 18 nucleotides of tRNAGlu.
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postulated to interact with the anticodon of tRNALys,3. These
changes that evolved in SIVsmmPBj occurred during the first
21 days of culture in human PBMC, even though the amount of
virus produced as determined by the JC53-BL assay is less than
that seen for the wild type virus.
Effect of mutations on two adenosine-rich RNA stem–loops in
the U5 of SIVsmmPBj
To further understand the significance of the nucleotide
changes within the U5 region in SIV-GluAC that lead to a
stabilization of the PBS complementary to tRNAGlu for a short
time, we analyzed the RNA structure of the U5-PBS using m-
fold. A previous study reported that the m-fold of the U5-PBS of
HIV-2, which is identical to this region in SIVsmmPBj revealed a
RNA stem–loop structure containing two adenosine-rich
regions (Berkhout, 1997) (Fig. 3). In our SIV-GluAC construct,
we mutated the second A-loop region to be complementary to
the anticodon region of tRNAGlu resulting in a new RNA stem–
loop that displayed the nucleotides complementary to the
anticodon region of tRNAGlu on an exposed loop (shaded area
in A-loop 2, Fig. 3). What was striking about the m-folds of
SIVsmmPBj was the existence of a second A-loop at the tip of a
RNA stem. The question arose as to whether or not this loop
structure could also impact the selection of the tRNA primer by
SIVsmmPBj and virus replication. To address this question, we
made two additional constructs. In the first, the adenosine
residues of the A-loop structure were mutated to cytidines,
resulting in a virus that we designated as SIV-CCA1 (Fig. 4A).In the second virus construct the adenosines of the second A-
loop were also mutated to cytidines, designated as SIV-CCA2.
Refolding of the new U5-PBS of these RNAs predicted an RNA
stem–loop structure in which only the loop region was altered
by the substitution of cytosines for adenosines.
Fig. 5. Replication of SIVsmmPBj genomes with mutations in A-loop 1 or A-loop
2. Infections were initiated with equal amounts of infectious virus in human
PBMC. The amount of virus produced was monitored by JC53-BL assay. At the
end of the experiment, the U5-PBS was amplified from the integrated provirus
of infected cells and DNA sequenced to determine the presence of the mutations.
The data presented are representative of three independent experiments.
Fig. 4. SIVsmmPBj genomes with mutations in the A-loop 1 or A-loop 2. (A) The
wild type SIVsmmPBj U5-PBS is presented with the two A-loop regions (boxed);
the PBS complementary to tRNALys,3 is shaded. The first mutant SIV-CCA1,
contains a mutation in A-loop 1 with two adenosines mutated to cytosines. A
second proviral genome, SIV-CCA2 contains mutation of two adenosines to
cytosines in A-loop 2. m-folds of the RNA from SIV-CCA1 and SIV-CCA2
revealed similar RNA structures as the wild type with the mutated nucleotide
substituted in the loop regions (data not shown). (B) Effect of the A-loop
mutations on virus production. The proviral genomes were transfected in the
293T cells and the amount of virus determined. There were no different effects
on the amount of virus produced as determined by the p27 antigen ELISA
capture assay. (C) Effect of the A-loop mutations on infectivity. The amount of
infectious virus produced from transfection was determined by the JC53-BL
assay and was compared to that obtained from transfection of SIV-WT (set at
100%). Both A-loop mutations resulted in a reduction in the amount of infec-
tious virus to 3 and 4% that of the wild type virus. Data are representative of
three independent transfections. (D) Effect of A-loop mutations on the
completion of reverse transcription. Equal amounts of the transfection super-
natant were used to infect human PBMC; 24-h later, PCR was used to determine
the amount of viral DNA present. The agarose gel is shown and the lanes are
labeled with the amount of high molecular weight DNA used in the PCR
reactions (i.e., 2, 4, and 10 ng). (E) The amount of product produced from PCR
was determined from the band intensity on a 1% agarose gel divided by that
obtained from SIV-WT (set at 100%); 2 ng samples are presented in figure.
Values presented are for three independent PCR reactions; values varied 2%
from each PCR reaction.
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production of infectious virus following transfection of the
proviral genomes. Themutations had no effect on the production
of virus as measured by p27 in the supernatant from transfectedcells (Fig. 4B). However, we found that both SIV-CCA1 and
SIV-CCA2 produced infectious virus at a level that was
approximately 3–4% that of the wild type as measured by the
JC53-BL assay (Fig. 4C). Thus, consistent with SIV-GluAC, we
found that mutations within the U5 drastically reduced the
production of infectious virus. We next analyzed the replication
of these viruses in PBMC. In the first experiments, we infected
PHA stimulated PBMC and then harvested high molecular
weight DNA after 24 h. PCR was used to analyze for the
presence of SIVsmmPBj DNA using primers specific for U5-PBS
(Fig. 4D). Compared to wild type, both the SIV-CCA1 and SIV-
CCA2 had less SIVsmmPBj DNA, consistent with the infectivity
results (Fig. 4C). We next analyzed the replication in long-term
PBMC culture. SIV-CCA1 replicated similar to the wild type
virus peaking at Day 11 post initiation of culture (Fig. 5). In
contrast, the virus SIV-CCA2 replicated much slower than the
wild type virus, demonstrating a gradual rise in production of
infectious virus throughout the culture period (39 days). Thus,
the mutations within the different A-loop regions had different
effects on the replication of these viruses.
To determine if the mutations were stable, we analyzed the
sequence of the U5 region of each virus at different times post
initiation of culture. Results of these studies demonstrated that
SIV-CCA1 rapidly reverted to the wild type sequence by
approximately 4 days after initiation of the culture (Table 2). In
fact, analysis of the DNA sequence of PCR product obtained
after a 24-h infection (Fig. 4C) revealed the presence of the wild
type sequence from the SIV-CCA1 culture. In contrast, the virus
SIV-CCA2 remained stable for the majority of the culture
period up to 32 days post initiation of culture. By Day 39 the
virus replication was approaching a level similar to that of the
wild type and we noted the reversion of the two cytidine to
adenosines, resulting in the wild type U5 sequence. Collec-
tively, the results of these studies demonstrate that SIVsmmPBj
contains two A-loop regions that have different effects on the
replication of the virus and in contrast to HIV-1, has a strong
Table 2
DNA sequences of U5-PBS region of proviruses derived from SIV-CCA1 and SIV-CCA2 grown in human PBMC
a Spaces separate the PBS from flanking sequences. Boldface characters indicate nucleotide changes made from the wild type sequence. Asterisks represent
conserved nucleotides with the input sequence.
b CCA1 and CCA2 input refers to either SIV-CCA1 or CCA2 viruses used to initiate culture. PCR products were sequenced directly when indicated.
Sequences of cloned PCR products are shown as frequencies of TA clones analyzed (i.e. number observed over total number analyzed).
c Number of days post inoculation of culture.
d PBS complementary to the 3′-terminal 18 nucleotides of tRNALys,3.
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mutations to restore these A-loop regions.
Discussion
In the current study, we have investigated the primer
selection preference of SIVsmmPBj using mutants in which the
PBS was altered to be complementary to tRNAGlu. A virus with
the PBS complementary to tRNAGlu was approximately 80% as
infectious as the wild type virus. However, after limited
replication in human PBMC, the virus reverted to utilize
tRNALys,3 as the primer. In HIV-1, a region 5′ to the PBS in U5
that is complementary to tRNALys,3 (A-loop) is important in
primer selection. A SIVsmmPBj construct in which the PBS and a
similar A-loop region were mutated to be complementary to
tRNAGlu was less than 1% as infectious as the wild type virus.
Although this virus did replicate in human PBMC, analysis of
the U5-PBS of this virus following replication revealed that
both the U5 and PBS had reverted to be complementary to
tRNALys,3 in some clones. To further explore the importance of
the U5 region in primer selection for SIVsmmPBj, we made
additional proviruses which contained mutations in two
adenosine-rich RNA stem–loop regions that could potentially
interact with the anticodon of tRNALys,3. Both viruses exhibited
profound reduction in infectivity, replicated more slowly than
the wild type virus and eventually reverted to be complementary
to the anticodon of tRNALys,3.
Lentiviruses such as HIV-1 and SIV have evolved to
preferentially select tRNALys,3 as a primer for reverse
transcription (Mak and Kleiman, 1997; Marquet et al., 1995).
Previous studies with HIV-1 have found that alteration of the
PBS to be complementary to alternative tRNAs results in the
virus reverting to utilize tRNALys,3 following short-term in vitro
replication (Das et al., 1995; Li et al., 1994; Wakefield et al.,
1995). In some cases, the virus can be forced to utilize
alternative tRNAs by additional mutations upstream in a region
that is complementary with the anticodon of the tRNALys,3 (A-loop) (Dupuy et al., 2003; Kang and Morrow, 1999; Kang et al.,
1999; Ni and Morrow, 2007; Wakefield et al., 1996). Previous
studies using enzymatic and chemical analysis have shown the
A-loop region interacting with the anticodon of tRNALys,3 in the
initiation complex (Isel et al., 1995). The intent of the current
study was to determine if SIVsmmPBj would also exhibit a
preferential selection of tRNALys,3 after mutation of the U5-
PBS. For our studies, we chose to mutate the PBS complemen-
tary to tRNAGlu, since previous studies from our laboratory
have shown that HIV-1 can be forced to use tRNAGlu with
mutations both in the U5 and PBS (Dupuy et al., 2003).
SIVsmmPBj was chosen for our studies because previous work
demonstrated this virus can replicate in human PBMC (Fultz
et al., 1989). Thus, we would be able to compare more directly
the primer preference of HIV-1 and SIVsmmPBj grown in the
same cells. Analysis of primer preference following replication
in the same cells should also eliminate concerns over differ-
ences in availability of tRNAs for primer capture.
The first difference between HIV-1 and SIVsmmPBj was
evident upon the analysis of the effect of altering the PBS in
SIVsmmPBj to be complementary to tRNA
Glu. This virus, SIV-
Glu retained approximately 80% of the infectivity of the wild
type virus while a similar mutation in HIV-1 results in a virus
with only 10% of the infectivity of the wild type virus. Ana-
lysis of the replication of SIV-Glu in human PBMC revealed
that the replication kinetics was very similar to the wild type
virus. Analysis of the PBS of integrated proviruses from
cultures only 4 days post initiation of infection revealed the
presence of PBS complementary to tRNALys,3, indicating that
reversion had occurred rapidly during replication of this virus.
In contrast, HIV-1 with a PBS complementary to tRNAGlu
replicated more slowly than the wild type virus and only
reverted after an extended time in culture (Dupuy et al., 2003).
The replication of HIV-1 in PBMC was more vigorous than
SIVsmmPBj as determined by production of infectious virus
(JC53-BL assay). The rapid reversion of SIVsmmPBj even with
the lower production of infectious virus suggests that the
336 M.C. Kelly et al. / Virology 366 (2007) 330–339primer selection process might actually be more stringent for
SIVsmmPBj. Why there would be a difference between
SIVsmmPBj and HIV-1 with respect to primer selection is unclear.
Previous studies from our laboratory have linked primer
selection with viral translation (Kelly and Morrow, 2003;
Kelly et al., 2003; Palmer et al., 2007). It is possible that in-
herent differences between SIVsmmPBj and HIV-1 viral transla-
tion, such as codon preference within Gag and Gag-pol could
impact on primer selection (Palmer et al., 2007). Additional
studies with more PBS mutants will be needed to resolve the
reason for the differences between SIVsmmPBj and HIV-1.
A second difference between SIVsmmPBj and HIV-1 with
respect to primer preference comes from the analysis of
SIVsmmPBj in which both the PBS and a region upstream of
the PBS (in the U5) were mutated to be complementary to
tRNAGlu (SIV-GluAC). In contrast to SIV-Glu, this virus had
greatly reduced infectivity compared to the wild type virus
(approximately 1%) and the replication of SIV-GluAC in
PBMC was delayed compared to that of the wild type virus,
eventually reaching wild type replication levels after extended
culture. Analysis of the U5-PBS at different times during the
culture period revealed that in some clones both the PBS and
A-loop region had reverted to wild type sequence. In contrast,
the A-loop regions of HIV-1 A-loop-PBS mutants did not revert
back to wild type (Dupuy et al., 2003; Kang and Morrow, 1999;
Kang et al., 1999; Wakefield et al., 1996; Zhang et al., 1998).
Previous studies have described the m-fold of the HIV-2
U5-PBS RNA (Berkhout, 1997) (there is a sequence identity of
the region of HIV-2 and SIVsmmPBj). Two possible A-loop
regions were noted in the m-fold. One of the A-loop regions
corresponded to the region mutated in the construction of the
SIV-GluAC (A-loop 2), while another A-loop region was found
upstream at the tip of a long RNA stem–loop (A-loop 1). To
ascertain the importance of these A-loop regions, we mutated
them individually and analyzed the effect on virus replication.
Although mutation of either A-loop did not effect the
production of total virus as measured by p27 (Fig. 4B), the
mutation of either A-loop had a great impact on the infectivity
of the virus derived from 293T cells as measured by PCR of
infected PBMC or the JC53-BL assay. Further support for the
importance of the adenosines in virus replication, comes from
the analysis of the stability of the mutations following
replication in PBMC. The mutation in A-loop 1 rapidly reverted
to the wild type sequence following short-term in vitro culture
(first detected after 24 h of infection). The reversion correlated
with the rapid increase in production of infectious virus in these
cultures, while the virus with mutations in A-loop 2 had delayed
replication resulting in slower growth as compared to the wild
type virus. However, during replication a reversion also
occurred which restored the second A-loop. The kinetics of
the reversion of virus with mutations in the second A-loop
region were similar to that observed for SIV-GluAC, which also
reverted the mutations in the A-loop back to the wild type
sequence. Based on our studies with HIV-1, we speculate that
the A-loop regions in SIVsmmPBj are involved in primer
selection. The dynamics of the interaction between the A-
loops and tRNALys,3 though are unclear. Since previous studieshave suggested the A-loop of HIV-1 interacts with the anticodon
of tRNALys,3 in a manner similar to codon:anticodon interaction
(Puglisi and Puglisi, 1998), it is possible that A-loop 1 of
SIVsmmPBj could function primarily to attract tRNA
Lys,3. The
sequence of the A-loop 2 region is identical to that of the HIV-1
A-loop. Previous studies have found that the A-loop of HIV-1
forms an intricate interaction with the anti-codon of tRNALys,3
in the initiation complex required for reverse transcription
(Goldschmidt et al., 2002; Isel et al., 1995). Although it has
been suggested that this region could also be involved with
integration (Masuda et al., 1998; Yoshinaga and Fujiwara,
1995), the key nucleotides for integration did not overlap with
our mutants. Thus, it is possible that SIVsmmPBj has evolved to
separate the individual functions of the HIV-1 A-loop. Further
studies though will be needed to resolve the roles of the
individual A-loops of SIVsmmPBj in reverse transcription.
Materials and methods
Construction of HIV-NL4.3 and SIVsmmPBj14 mutant proviral
genomes
Construction of pHXB2(Glu) and pHXB2(Glu Loop 1) with
U5-PBS changes complimentary to tRNAGlu was previously
described (Dupuy et al., 2003). The proviral clones pHXB2
(Glu) and pHXB2(Glu Loop 1) were digested with the
restriction enzymes HpaI and BssHII (New England Biolabs,
Beverly, MA) to release a 868 base pair fragment containing the
5′ long terminal repeat, PBS, and leader region of gag. This 868
base pair fragment was isolated via gel extraction using the
Qiagen QIAquick Gel Extraction kit (Qiagen, Valencia, CA)
and cloned between the HpaI and BssHII sites of the HIV-
NL4.3 proviral plasmid, producing the molecular clones
pNL4-Glu and pNL4-GluAC.
The infectious molecular clone 1.9 of SIVsmm isolate PBj14
(SIVsmmPBj) was obtained from Patricia Fultz, Department of
Microbiology, University of Alabama at Birmingham. The 5′
long terminal repeat, PBS, and leader region of gag of this clone
were inserted into the multiple cloning site, XhoI-to-Eco47III
(New England Biolabs and Promega, Madison, WI, respec-
tively), of the pSE420 vector (Invitrogen, Carlsbad, CA). The
resulting vector, named pSE420-PBj, served as a template for
mutagenesis using the QuikChange II Site-Directed in vitro
mutagenesis kit (Stratagene, La Jolla, CA). The PBS was
mutated to a sequence complementary to the 3′-terminal 18
nucleotides of tRNAGlu forming the mutant pSE420-PBj(Glu).
The pSE420-PBj(Glu) vector was then used as the template to
make additional mutations upstream of the PBS sequence in a
region that appeared to resemble the A-loop of HIV-1, forming
the mutant vector pSE420-PBj(GluAC). The pSE420-PBj
vector was used to make mutations to disrupt two adenosine-
rich loops forming the mutant vectors pSE420-PBj(CCA1) and
pSE420-PBj(CCA2). The mutagenic primers used to make these
mutations were: GluF(5′CCCTAGCAGGTTGGTTCCCTGA-
CCGGGAATTGAAGGAGAGTGAGAGCTCC3′), GluR (5′
GGAGCTCTCACTCTCCTTCAATTCCCGGTCAGGGAAC-
CAACCTGCTAGGG3′), GluACF (5′ CCTTTCTGCTTTGG-
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GTTCCCTGAGGG 3′), GluACR(5′CCCGGTCAGGGAAC-
CAACCTGCTAGGGACTCAACTCTAGCCTCGGTTTCCC-
AAAGCAGAAAGG3′), CCA1F (5′G GGAAACCGAGGCA-
GGACCATCCCTAGCAGGTTGGCGC CCG3′), CCA1R (5′
CGGGCGCCAACCTGCTAGGGATGGTCCTGCCT-
CGGTTTCCC3′), CCA2F(5′ GGACCCTTTCTGCTTTGGG-
ACCACGAGGCAGGAAAATCCCTAGCAGG3′), CCA2R
(5′CCTG CTAGGGATTTTCCTGCCTCGTGGTCCCAAAG-
CAGAAAGGGTCC3′). All mutagenesis was performed ac-
cording to the manufacturer's instructions, and the resulting
mutant sequences were verified by DNA sequencing. The 1356
base pair XhoI-to-Eco47III fragments of pSE420-PBj(Glu),
pSE420-PBj(GluAC), pSE420-PBj(CCA1) and pSE420-PBj
(CCA2) containing the U5 and PBS regions were subcloned
between the XhoI and Eco47III sites in the molecular clone 1.9
of SIVsmmPBj14 to form the complete proviral clones pSIV-Glu,
pSIV-GluAC, pSIV-CCA1 and pSIV-CCA2. All proviral clones
were screened by restriction digestion, and the sequences were
verified by DNA sequencing to ensure successful mutagenesis
and subsequent ligation into the proviral plasmid, either pNL4
or pSIV.
Tissue culture
All cultures were maintained at 37 °C with 5% CO2. Both
JC53-BL, obtained from the National Institutes of Health
AIDS Research and Reference Reagent Program, and 293T
cells were grown in Dulbecco's modified Eagle's medium
(DMEM; Gibco BRL, Rockville, MD) supplemented with
10% fetal bovine serum (FBS; Hyclone, Logan, UT) and 1%
penicillin–streptomycin–L-glutamine mix (penstrep-glu; Cell-
gro® by Mediatech, Inc., Herdon, VA). Human peripheral
blood mononuclear cells (PBMC) were isolated from HIV-1-
seronegative whole blood (from two donors) by Ficoll-
Hypaque (Amersham Pharmacia Biotech, Piscataway, NJ)
density gradient centrifugation. PBMC were aliquoted and
stored in liquid nitrogen at −140 °C. To begin an infection,
PBMC were thawed and stimulated with 3 μg/mL of
phytohemagglutinin (Sigma, St. Louis, Mo.) for 3 days in
PBMC media, which contains Roswell Park Memorial
Institute 1640 medium (RPMI; Cellgro) supplemented with
15% FBS, 1% penstrep-glu, and 30 U/mL recombinant human
interleukin-2 (rIL-2; Roche Molecular Biochemicals, Indiana-
polis, IN). After stimulation, the medium was removed and
replaced with fresh PBMC medium. PBMC were incubated for
another 2 days before being infected with virus.
Virus production and analysis of viral infectivity
Transfections were performed in 293T cells that were
approximately 70% confluent in a six-well cell culture plate
using the appropriate pNL4 or pSIV proviral DNA plasmid
and FuGENE 6 transfection reagent (Roche Molecular
Biochemicals). Briefly, 3 μg of FuGENE 6 transfection
reagent and 2 μg of proviral DNA plasmid were added to
100 μL DMEM (without FBS) and incubated at roomtemperature for 45 min. Each transfection cocktail was
added, drop-wise, to one of the wells containing the 293T
cells. The plates were incubated at 37 °C with 5% CO2. After
24 h, the media were removed and replaced with fresh DMEM
supplemented with 10% FBS and 1% penstrep-glu. At 72 h
post-transfection, the virus supernatants were removed,
microcentrifuged to remove cells, and then stored at −80 °C.
To determine the amount of virus produced from the
transfection, the supernatants were assayed for either p24 for
HIV-1 or p27 for SIVsmmPBj using the Beckman Coulter p24
antigen ELISA kit (Beckman Coulter, Miami, FL) and the
Retro Tek SIV p27 antigen ELISA kit (Zepto Metrix, Buffalo,
NY). The number of infectious units (IU) contained in the
supernatants was determined by the JC53-BL β-Gal assay.
JC53-BL indicator cells are a derivative of HeLa cells that not
only express high levels of CD4, CCR5, and CXCR4, but also
contain a reporter cassette of β-galactosidase that is expressed
from an HIV-1 promoter. Expression of the reporter genes is
dependent on production of the viral protein Tat. Therefore,
the cells are indicators of viral infectivity that is contained
within a given volume. The JC53-BL β-Gal assays were
preformed as described previously (Derdeyn et al., 2000). To
initiate PBMC infection, virus transfection supernatant con-
taining 250 IUs was used to infect 2×107 PBMC. The long-
term PBMC cultures were passaged 1:2 alternating every 3
and 4 days. Supernatants were collected from PBMC infected
cultures at every passage. Every 14 days, 5×106 newly thawed
and stimulated PBMC, as described above, were added to
replenish cells that had died. To determine the replication
kinetics of the viruses in culture, the culture supernatants were
used to infect JC53-BL cells and a JC53-BL luciferase assay
was performed. In addition to the β-galactosidase, JC53-BL
cells also contain a reporter cassette of luciferase that is
controlled by the same HIV-1 promoter. For each assay, 6×103
JC53-BL cells were plated 1 day prior to infection. Equal
amounts of the culture supernatants in the presence of DEAE-
dextran (3 μg) in a final volume of 60 μL were added to the
monolayer of JC53-BL cells. Plates were incubated at 37 °C
with 5% CO2 and then 140 μL of DMEM with 10% FBS and
1% penstrep-glu was added to the wells. Plates were incubated
for another 48 h at 37 °C with 5% CO2. To determine the
luciferase activity, cells were lysed using M-PER mammalian
protein extraction reagent (Pierce, Rockford, IL) and 20 μL of
each lysate was transferred to a microplate. Reporter lysis
buffer (Promega) was added to each sample in the microplate,
and the light intensity was measured using a LUMIstar
luminometer (BMG Labtech, Durham, NC). The luminescence
emitted from uninfected cells was used as background levels
and was subtracted from all other samples. The luciferase
values for two dilutions per sample were averaged. Relative
light units (rLu) per μL were calculated by dividing the
luciferase values by their corresponding dilution values.
DNA sequence analysis of proviral U5 and PBS regions
Cell pellets were collected 24-h post-infection of PBMC for
single-round culture and from the long-term PBMC cultures at
338 M.C. Kelly et al. / Virology 366 (2007) 330–339every passage. High molecular weight (HMW) DNA was
obtained from these cell pellets using theWizard Genomic DNA
isolation kit (Promega) according to the manufacturer's proto-
col. A 506 base pair fragment containing the U5 and PBS regions
of the integrated provirus was amplified from the HMW
template DNA by PCR with the primers PBjF (5′TTTCCA-
CAAAGGGGATGTTACG3′) and PBjR (5′CGCCTTTATAG-
GAGCACTCCG3′) under the following PCR conditions: Step
1: 95 °C for 5 min, Step 2: 95 °C for 1 min, Step 3: 62 °C for
1 min, Step 4: 72 °C for 1 min, Step 5: Goto Step 2, 33 more
times, Step 6: 72 °C for 15 min, and Step 7: Keep at 4 °C. The
PCR reactions for the 24-h PBMC cultures of SIV-WT, SIV-
CCA1, and CCA2 contained 2 ng, 4 ng, and 10 ng of HMW
template DNA. The negative control PCR reaction contained
10 ng of HMW from uninfected PBMC. The PCR products
were run on a 1% agarose gel containing ethidium bromide. The
intensity of the bands was then quantified using the image
analysis software ImageJ 13.7v (Abraham et al., 2004). The
PCR products from the long-term PBMC cultures were
sequenced directly or clones of the PCR product were ligated
into the pGEM-T Easy vector (Promega) according to the
manufacturer's protocol and then sequenced using the primer
PBjF.
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